Common use of General Items Clause in Contracts

General Items. 一般條款 1. Business tax arising from the performance of the Agreement shall be borne by Party B, stamp duty shall be borne by each party, and other taxes shall be borne by the party who incurred them. 因契約之履行所衍生之營業稅由乙方負責，印花稅各自負擔，其它稅賦由發生之一方負擔。 2. This Agreement shall not be modified without the written consent of both parties. If there is a need for amendment, both parties agree to amend this Agreement in good faith, and the same applies to any other unfinished matters. 本契約未經甲、乙雙方書面同意，不得任意修改。如有修訂之必要時，雙方同意以誠實信用之態度，協議修訂之，如有其他未竟事宜時，亦同。 3. Except as otherwise provided in this Agreement, neither party shall assign this Agreement or its rights and obligations hereunder, in whole or in part, to a third party without the prior written consent of the other party. 除本契約另有約定外，任一方未經他方當事人事前書面同意，不得將本契約或其基於本契約之權利及義務全部或任何部分轉讓予第三人。 4. In the event that any provision of this Agreement is invalidated because of a violation of a mandatory or prohibited provision of law, the parties agree that such violation shall be invalid only with respect to that portion, and shall not affect the validity of the other provisions of this Agreement. 本契約任何規定如因違反法律強行或禁止規定致無效時，雙方同意僅就該抵觸部分為無效，不影響本契約其他條款之效力。 5. Both parties agree that the documents to be expressed in writing shall be addressed to the designated contact person and contact method specified below. In case of any change in the contact person and contact method, both parties shall notify each other in writing, and the change shall be effective from the date when the written notice is received: 雙方同意應以書面表示之文件，均以下指定之聯絡人及聯絡方式為準。雙方之契約聯絡人及聯絡方式如有異動，應以書面通知對方，並自書面通知到達日起生效： Party A: 甲方 3D GLOBAL BIOTECH INC. 三鼎生物科技股份有限公司 地址：新北市汐止區新台五路▇段▇▇號▇▇樓之▇ Address: 21F.-1, No.99, Sec. ▇, ▇▇▇▇▇▇ ▇▇▇ ▇▇., ▇▇▇▇▇ ▇▇▇▇., ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇ TEL: (▇▇) ▇▇▇▇-▇▇▇▇#▇▇▇ (▇▇▇▇▇ ▇▇▇▇) 電話：(▇▇) ▇▇▇▇-▇▇▇▇#▇▇▇ (詹育豪) Email: ▇▇▇▇▇.▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇.▇▇ 信箱：▇▇▇▇▇.▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇.▇▇ Party B: 乙方 Yong Ding Biopharm Co., Ltd. 永鼎醫藥股份有限公司 地址：臺北市中山區南京東路▇段▇▇▇號▇▇樓 Address: 12F., No. 101, Sec. 2, Nanjing E. Rd., Zhongshan Dist., Taipei City TEL: (▇▇) ▇▇▇▇-▇▇▇▇ 電話：(▇▇) ▇▇▇▇-▇▇▇▇ Email: ▇▇▇▇▇▇▇▇▇@▇▇▇-▇▇▇▇▇.▇▇▇ 信箱：▇▇▇▇▇▇▇▇▇@▇▇▇-▇▇▇▇▇.▇▇▇ 6. The validity of this Agreement and its interpretation shall follow the relevant laws and regulations of R.O.C. Matters not covered in this Agreement shall be resolved by mutual agreement between the parties in good faith. In case of disputes and lawsuits arising out of this Agreement, both parties agree that the Taiwan Taipei District Court shall be the court of first instance, except that in case of disputes relating to intellectual property, the Intellectual Property and Commercial Court shall be the court of first instance, and that the application of any applicable foreign-related civil laws, election laws or other relevant regulations shall be excluded. 本契約之效力與其釋義應遵循中華民國相關法律及規定。本契約未盡事宜，雙方應本誠信原則互相協議解決。如因本契約衍生之爭議與訴訟，甲乙雙方同意以台灣台北地方法院為第一審管轄法院，惟如係有關於智慧財產之爭議，則以應以智慧財產與商業法院為第一審管轄法院，並排除任何涉外民事法律適用法、選法或其他相關規定之適用。 7. This Agreement and the Attachments hereto constitute the entire agreement between the parties with respect to the license and the cooperative development, and shall supersede all prior negotiations, contracts or agreements between the parties. 本契約及其附件構成雙方對本授權及合作開發之完整合意，並取代先前雙方先前一切協商、契約或合意。 8. The Annexes shall have the same effect as this Agreement, except that in the event of any conflict between the two, this Agreement shall prevail. 附件之效力與本契約同，惟若兩者有牴觸時，以本契約為準。 9. This Agreement is in two copies, Party A and Party B each keeps a copy of this Agreement. 本契約壹式貳份，由甲、乙雙方各執壹份為憑。 （以下為「簽署頁」） 3D GLOBAL BIOTECH INC. 三鼎生物科技股份有限公司 ▇▇▇▇ ▇▇▇▇ Biopharm Co., Ltd. 永鼎醫藥股份有限公司 Address: ▇▇▇.-▇, ▇▇.▇▇, ▇▇▇. ▇, ▇▇▇▇▇▇ ▇▇▇ ▇▇., ▇▇▇▇▇ ▇▇▇▇., ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇ Address: ▇▇▇, ▇▇.▇, ▇▇▇▇ ▇▇ ▇▇., ▇▇▇▇▇▇▇ ▇▇▇▇., ▇▇▇▇▇▇ ▇▇▇▇ 地址：新北市汐止區新台五路▇段▇▇號▇▇樓之▇ By:__________________________________ 簽署人： 地址：臺北市南港區園區街▇號▇▇樓 By:__________________________________ 簽署人： Title: Title: 職稱： 職稱 Signature and effective date: 2024.06.19 簽署暨生效日：中華民國 113年06月19日 1. Patent - METHODS OF CULTURING HUMAN CORNEAL LIMBUS CELLS 本專利--「培養人類角膜緣細胞之方法」（METHODS OF CULTURING HUMAN CORNEAL LIMBUS CELLS） 1. 專利申請號：US15/967,401、公開號為US20190062704A1 Patent Application Number: US15/967,401, Publication Number: US20190062704A1 2. Know-How 本專門技術 1. Process of LSC Cell Culture (LSC細胞培養製程) 2. Establishment of Cell Banks (細胞庫建置工程) 3. Technique of Exosomes Purification/Assessment (外泌體純化暨鑑定技術) 4. Production of Exosomes (外泌體生產) 5.